ParsiKZhangL. 899 serious adverse events including 13 deaths, 7 strokes, 211 thromboembolic events, and 482 immune reactions: the untold story of cyanoacrylate adhesive closure. Phlebology2024; 39: 80–95. DOI: 10.1177/0268355523_1211086
2.
BozkurtAK. [LETTER IN THIS ISSUE].
3.
EliasSLabropoulosNBlaxkS, et al.[LETTER IN THIS ISSUE].
4.
Esponda OL. [LETTER IN THIS ISSUE].
5.
ParsiKGraceJConnorD. [AUTHORS REPLY TO THE CORRESPONDENCE].
6.
Garcia-CarpinteroECarmonaMChaloco-OrregoJP, et al.Systematic review and meta-analysis of endovenous cyanoacrylate adhesive ablation for incompetent saphenous veins. J Vasc Surg Venous and Lymphat Disord2020; 8: 287–296.
7.
ForleeMVGroudenMMooreDJ, et al.Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg2006; 43: 162–164.
8.
BushRGDerrickMManjoneyD. Major neurological events following foam sclerotherapy. Phlebology2008; 23: 189–192.
9.
CavezziAParsiK. Complications of foam sclerotherapy. Phlebology2012; 27(Suppl 1): 46–51.
10.
MalgorRFGasparisAPLabropoulosN. Morbidity and mortality after thermal venous ablations. Int Angiol2016; 35: 57–61.
11.
HealyDAKimuraSPowerD, et al.A systematic review and meta-analysis of thrombotic events following endovenous thermal ablation of the great saphenous vein. Eur J Vasc Endovasc Surg2018; 56: 410–424.
12.
GibsonKMinjarezRRinehardtE, et al.Frequency and sensitivity of hypersensitivity reactions in patients after VenaSeal TM cyanoacrylate treatment of superficial venous insufficiency. Phlebology2020; 35: 337–344. DOI: 10.1177/0268355519878618
13.
JonesADBoyleEMWoltjerR, et al.Persistent type IV hypersensitivity after cyanoacrylate closure of the great saphenous vein. J Vasc Surg Cases and Innovative Techniques2019; 53: 72–74.
14.
AthavaleAThaoMSassakiVS, et al.Cyanoacrylate glue reactions: a systematic review, cases, and proposed mechanisms. J Vasc Surg Venous Lymphat Disord2023; 11(e.1): 876–888.
15.
VasquezMADi IorioMWorthington-KirschRL, et al.Current practise of cyanoacrylate endovenous ablation: American vein and lymphatic society position statement. Phlebology2024; 39: 245–250. DOI: 10.1177/02683555_231221862
16.
UmetsuMHirokawaMFukayaE, et al.Serious adverse events with cyanoacrylate closure of varicose veins: an initial report from a large-scale national survey in Japan. Ann Vasc Dis2024; 17: 21–24.
17.
CampbellBStainthorpeALongsonC. How can we get high quality routine data to monitor the safety of devices and procedures?BMJ2013; 346: f2782.
18.
SedrakyanACampbellBGravesS, et al.Surgical registries for advancing quality and device surveillance. Lancet2016; 388: 1358–1360.
